Alkermes plc. (ALKS) stock
ALKSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30213% above fair value
$47.89+1.42 (+3.06%)
Close on Nov 11, 2026Market cap $8.03BP/E 126.0Yield –
Alkermes enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Alkermes's enterprise value was $8.87B on Nov 11, 2026, against $3.77B a year earlier. Over the last 5 years it ranged from $3.38B to $9.72B, with a median of $4.08B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $8.87B | +152.8% |
| 2025 | Dec 31, 2025 | $3.51B | -13.0% |
| 2024 | Dec 31, 2024 | $4.03B | +0.1% |
| 2023 | Dec 29, 2023 | $4.03B | +0.5% |
| 2022 | Dec 30, 2022 | $4.01B | +14.6% |
| 2021 | Dec 31, 2021 | $3.50B | +21.4% |
| 2020 | Dec 31, 2020 | $2.88B | -0.8% |
| 2019 | Dec 31, 2019 | $2.90B | -34.0% |
| 2018 | Dec 31, 2018 | $4.40B | -46.7% |
| 2017 | Dec 29, 2017 | $8.25B | +0.9% |
| 2016 | Dec 30, 2016 | $8.17B | -28.8% |
| 2015 | Dec 31, 2015 | $11.48B | +43.8% |
| 2014 | Dec 31, 2014 | $7.98B | +42.9% |
| 2013 | Dec 31, 2013 | $5.59B | +114.2% |
| 2012 | Dec 31, 2012 | $2.61B | +5.2% |
| 2011 | Dec 30, 2011 | $2.48B | +128.3% |
| 2010 | Dec 31, 2010 | $1.09B | – |
See a number that looks wrong?